11/2016 Admera Health Vice President, Brady Millican and Senior Scientific Liaison, Sue-Ann Woo, PhD are interviewed on the award-winning, global TV show, Worldwide Business with kathy ireland®. The segment’s topic is the introduction of personalized precision medicine with next-generation technology.
10/2016 Based on its recent analysis of the market for NGS molecular diagnostics, Frost & Sullivan recognizes Admera with the 2016 North American Frost & Sullivan Award for Technology Innovation. Admera earned this honor for delivering a range of molecular tests that span the entire continuum of patient care.
08/2016 Dr. Dan Jacoby discusses the utility of genetic testing for inherited cardiovascular disease and sudden cardiac death risk; specifically, the need for familial screening of first degree relatives. Three case studies are reviewed in which genetic testing via CardioGxOne™ aided differential diagnosis and provided guidance for treatment decisions. To learn more visit www.admerahealth.com/cardiogxone
08/2016 Dr. Lorenzo Monserrat of Health in Code, Admera’s collaborator in cardiology genetic sequencing, introduces NGS as a tool for diagnosing inherited cardiovascular disease. Using examples of clinical interpretation, he demonstrates the effectiveness of including NGS in a multidisciplinary approach to cardiovascular disease testing.